Methods and pharmaceutical compositions for treating microbiome dysregulations associated with circadian clock disruption
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite De Lille, Institut Pasteur de Lille, Centre National de la Recherche Scientifique (CNRS)
InventorMathias CHAMAILLARD
Life of this patent
Estimating the term…